Login to Your Account

OSI Agrees To $135M Notes Sale, Enters Structural GenomiX Deal

By Randall Osborne

Thursday, September 4, 2003
Entering a research deal with Structural GenomiX Inc. that's intended to speed up the testing of drug leads, OSI Pharmaceuticals Inc. separately agreed to issue $135 million in convertible notes in a private placement. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription